StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 19, 2026, 06:08 AM

Natural Alternatives Q3 Net Loss $(4.31)M; Sales $35.48M

AI Summary

Natural Alternatives International Inc. reported a net loss of $(4.31) million for the three months ended March 31, 2026, worsening from a net loss of $(2.19) million in the prior year, despite net sales increasing to $35.48 million. For the nine-month period, net sales rose to $108.01 million, but the company's net loss also widened to $(7.16) million. The company experienced a significant decrease in cash and cash equivalents and increased its line of credit borrowing.

Key Highlights

  • Net sales for Q3 2026 increased to $35.48 million from $28.77 million in Q3 2025.
  • Net loss for Q3 2026 widened to $(4.31) million from $(2.19) million in Q3 2025.
  • Basic EPS for Q3 2026 was $(0.72), compared to $(0.37) in Q3 2025.
  • Nine-month net sales increased to $108.01 million from $95.99 million year-over-year.
  • Nine-month net loss widened to $(7.16) million from $(6.36) million year-over-year.
  • Cash and cash equivalents decreased to $9.20 million from $12.33 million since June 30, 2025.
  • Line of credit borrowing increased to $10.00 million from $1.90 million since June 30, 2025.
  • Net cash used in operating activities was $(7.85) million for the nine months, compared to $2.59 million provided in prior year.